Title:
CCK COMPOSITIONS
Document Type and Number:
WIPO Patent Application WO/2012/136792
Kind Code:
A3
Abstract:
The present invention relates to drug fusions and conjugates that have improved serum half lives. These fusions and conjugates comprise immunoglobulin (antibody) single variable domains and insulintropic and/or incretin and/or gut peptide molecules. The invention further relates to uses, formulations, compositions and devices comprising such drug fusions and conjugates. The invention also relates to compositions which comprise more than one insulintropic and/or incretin and/or gut peptide molecules present as part of a fusion or conjugate and to uses and formulations thereof.
Inventors:
MCGREGOR JOANNE (GB)
Application Number:
PCT/EP2012/056330
Publication Date:
December 13, 2012
Filing Date:
April 05, 2012
Export Citation:
Assignee:
GLAXO GROUP LTD (GB)
MCGREGOR JOANNE (GB)
MCGREGOR JOANNE (GB)
International Classes:
A61K47/48; C12N15/62
Domestic Patent References:
| WO2006059106A2 | 2006-06-08 | |||
| WO2009121804A1 | 2009-10-08 | |||
| WO2011039096A1 | 2011-04-07 |
Attorney, Agent or Firm:
KUCERNAK, Lynn et al. (Global Patents CN925.1980 Great West Road, Brentford Middlesex TW8 9GS, GB)
Download PDF:
Previous Patent: METHOD AND DEVICE FOR SWITCHING WINDING SHAFTS
Next Patent: OPTICAL DETECTION OF CYANIDES, METHOD, KIT AND DEVICE
Next Patent: OPTICAL DETECTION OF CYANIDES, METHOD, KIT AND DEVICE